Company profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Neumora Therapeutics, Inc.
12 Dec 23
4
Neumora Therapeutics, Inc.
20 Sep 23
3
Neumora Therapeutics, Inc.
14 Sep 23
4
KEITH CRANDELL
15 Sep 22
4
CLINTON BYBEE
24 Nov 20
4
KEITH CRANDELL
20 Oct 20
3
KEITH CRANDELL
13 Oct 20
4
KEITH CRANDELL
22 Sep 20
3
KEITH CRANDELL
15 Sep 20
4
KEITH CRANDELL
12 Aug 19
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Dec 23 | ARCH Venture Partners X | Common Stock | Other | Acquire J | Yes | No | 0 | 1,176,593 | 0.00 | 2,321,566 |
8 Dec 23 | ARCH Venture Partners X | Common Stock | Other | Acquire J | Yes | No | 0 | 703,061 | 0.00 | 1,387,228 |
19 Sep 23 | ARCH Venture Partners X | Common Stock | Buy | Acquire P | Yes | No | 17 | 1,500,000 | 25.50 mm | 3,624,143 |
19 Sep 23 | ARCH Venture Partners X | Common Stock | Conversion | Acquire C | Yes | No | 0 | 2,124,143 | 0.00 | 2,124,143 |
19 Sep 23 | ARCH Venture Partners X | Common Stock | Conversion | Acquire C | Yes | No | 0 | 6,576,400 | 0.00 | 11,886,758 |
19 Sep 23 | ARCH Venture Partners X | Common Stock | Conversion | Acquire C | Yes | No | 0 | 6,895,021 | 0.00 | 12,205,379 |
19 Sep 23 | ARCH Venture Partners X | Common Stock | Conversion | Acquire C | Yes | No | 0 | 1,144,973 | 0.00 | 1,144,973 |
19 Sep 23 | ARCH Venture Partners X | Common Stock | Conversion | Acquire C | Yes | No | 0 | 684,167 | 0.00 | 684,167 |
19 Sep 23 | ARCH Venture Partners X | Series B Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 2,124,143 | 0.00 | 0 |
19 Sep 23 | ARCH Venture Partners X | Series A-2 Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 6,576,400 | 0.00 | 0 |